Pieris Pharmaceuticals, Inc.: Platform technology company developing Anticalin proteins (engineered human lipocalins) for respiratory diseases and oncology. Recently showed Ph 1 data for data for: 1) AZN-partnered PRS-060 for moderate-to-severe asthma (targeting IL4RA through inhalation) and 2) fully-proprietary IO program PRS-343 for HER2+ solid tumors (targeting 4-1BB and HER2). Additional IO partnerships w/ Servier and Seattle Genetics.
Sector/industry:
Healthcare/Biotechnology
Characteristics:
Based in...
US - New England
Clinical Stage
Phase l or ll
Disease Space
Immuno-Oncology, Immunotherapy, Oncology, Respiratory
Finance
Pre-earnings
Industry
Biotechnology
Listing
Public, USA
Market Cap
100MM - 500MM
Therapeutic Modalities
Antibodies, Platform Technology
Website:
Profiles:
Address:
255 State Street
Boston, MA 02109
United States

Company Participants at Pieris Pharmaceuticals R&D Day

  • Stephen S. Yoder, CEO

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Lead Programs

PRS-060

Indication Phase
IL4-Rα 1

PRS-343

Indication Phase
HER2/4-1BB 1
+ Anti-PD-L1 1

Top 10 Holders of Pieris Pharmaceuticals, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
BVF, Inc. 9.88 5,349,905 18.46 13F 2019-09-30
Ecor1 Capital LLC 9.36 5,070,424 17.49 Stakes 2019-11-04
Aquilo Capital Management LLC 5.46 2,958,243 10.21 13F 2019-09-30
Renaissance Technologies LLC 4.04 2,188,200 7.55 13F 2019-09-30
Acadian Asset Management LLC 3.49 1,887,466 6.51 13F 2019-09-30
BVF Partners LP 3.40 1,841,870 6.35 Stakes 2019-09-06
BlackRock Fund Advisors 3.24 1,752,569 6.05 13F 2019-09-30
Tekla Capital Management LLC 2.68 1,449,269 5.00 13F 2019-09-30
Candriam Belgium SA 2.40 1,301,000 4.49 Funds 2019-11-29
BlackRock Institutional Trust Co. NA 2.38 1,291,313 4.46 13F 2019-09-30

Top 10 Holders of Pieris Pharmaceuticals, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
BVF Partners LP 0.04 2,907 0.01 Stakes 2019-09-06

Top 10 Holders of Pieris Pharmaceuticals, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
BVF Partners LP 100.00 5,000 0.02 Stakes 2019-09-06
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.